Key result
Innate immunity drives vascular inflammation and systemic disease, highlighting key therapeutic targets.
Sustained inflammation of the vessel walls occurs in a large number of systemic diseases (ranging from atherosclerosis to systemic vasculitides, thrombotic microangiopathies and connective tissue diseases), which are ultimately characterized by ischemia and end-organ failure. Cellular and humoral innate immunity contribute to a common pathogenic background and comprise several potential targets for therapeutic intervention. Here we discuss some recent advances in the effector and regulatory action of neutrophils and in the outcome of their interaction with circulating platelets. In parallel, we discuss novel insights into the role of humoral innate immunity in vascular inflammation. All these topics are discussed in light of potential clinical and therapeutic implications in the near future.
No takes yet. Share an insight, caveat, or question.
Ramirez et al. (2015) conducted a review in Vascular inflammation. Cellular and humoral innate immunity play key roles in the pathogenesis of vascular inflammation and systemic diseases, representing potential targets for future therapeutic intervention.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: